Peptide-induced de novo bone formation after tooth extraction prevents alveolar bone loss in a murine tooth extraction model.

[1]  N. Wakabayashi,et al.  A threshold of mechanical strain intensity for the direct activation of osteoblast function exists in a murine maxilla loading model , 2016, Biomechanics and modeling in mechanobiology.

[2]  N. Sims,et al.  Is RANKL inhibition both anti-resorptive and anabolic in rheumatoid arthritis? , 2015, Arthritis Research & Therapy.

[3]  N. Wakabayashi,et al.  The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study , 2015, Arthritis Research & Therapy.

[4]  J. Lindhe,et al.  Ridge alterations following grafting of fresh extraction sockets in man. A randomized clinical trial. , 2015, Clinical oral implants research.

[5]  H. Schliephake Clinical efficacy of growth factors to enhance tissue repair in oral and maxillofacial reconstruction: a systematic review. , 2015, Clinical implant dentistry and related research.

[6]  M. Bouxsein,et al.  Cortical and trabecular load sharing in the human femoral neck. , 2015, Journal of biomechanics.

[7]  T. Martin,et al.  RANKL/OPG; Critical role in bone physiology , 2015, Reviews in Endocrine and Metabolic Disorders.

[8]  L. Duong,et al.  PDGF-BB secreted by preosteoclasts induces CD31hiEmcnhi vessel subtype in coupling osteogenesis , 2014, Nature Medicine.

[9]  M C Sogayar,et al.  Bone Morphogenetic Proteins , 2014, Journal of dental research.

[10]  M. Viñas,et al.  Risk factors for denture-related oral mucosal lesions in a geriatric population. , 2014, The Journal of prosthetic dentistry.

[11]  Y. Tabata,et al.  Gelatin hydrogel carrier with the W9-peptide elicits synergistic effects on BMP-2-induced bone regeneration , 2013 .

[12]  Chunyan Li,et al.  Adrenomedullin delivery in microsphere-scaffold composite for remodeling of the alveolar bone following tooth extraction: an experimental study in the rat , 2013, Biomedical engineering online.

[13]  E. Hurwitz,et al.  Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis. , 2013, The Journal of bone and joint surgery. American volume.

[14]  N. Wakabayashi,et al.  The influence of mechanical stimulation on osteoclast localization in the mouse maxilla: bone histomorphometry and finite element analysis , 2013, Biomechanics and modeling in mechanobiology.

[15]  K. Aoki,et al.  The local administration of TNF-α and RANKL antagonist peptide promotes BMP-2-induced bone formation , 2013 .

[16]  J. Penninger,et al.  Stimulation of Bone Formation in Cortical Bone of Mice Treated with a Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-binding Peptide That Possesses Osteoclastogenesis Inhibitory Activity , 2013, The Journal of Biological Chemistry.

[17]  J. Kanis,et al.  Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  K. Aoki,et al.  Peptide-based delivery to bone. , 2012, Advanced drug delivery reviews.

[19]  K. Aoki,et al.  A structural modulator of tumor necrosis factor type 1 receptor promotes bone formation under lipopolysaccharide-induced inflammation in a murine tooth extraction model. , 2012, European journal of pharmacology.

[20]  M. Wong,et al.  A systematic review of post-extractional alveolar hard and soft tissue dimensional changes in humans. , 2012, Clinical oral implants research.

[21]  D. Kim,et al.  Human buccal plate extraction socket regeneration with recombinant human platelet-derived growth factor BB or enamel matrix derivative. , 2011, The International journal of periodontics & restorative dentistry.

[22]  M. E. Corrêa,et al.  Clinical and histomorphometric evaluation of extraction sockets treated with an autologous bone marrow graft. , 2010, Clinical oral implants research.

[23]  Yasuhiko Tabata,et al.  Bone Regeneration Using a Bone Morphogenetic Protein-2 Saturated Slow-Release Gelatin Hydrogel Sheet: Evaluation in a Canine Orbital Floor Fracture Model , 2010, Annals of plastic surgery.

[24]  In Gwun Jang,et al.  Computational simulation of simultaneous cortical and trabecular bone change in human proximal femur during bone remodeling. , 2010, Journal of biomechanics.

[25]  Hiroshi Suzuki,et al.  Vps33a Mediates RANKL Storage in Secretory Lysosomes in Osteoblastic Cells , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  K. Aoki,et al.  LPS‐Induced Inhibition of Osteogenesis Is TNF‐α Dependent in a Murine Tooth Extraction Model , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  P. Guy,et al.  Cortical and trabecular bone in the femoral neck both contribute to proximal femur failure load prediction , 2009, Osteoporosis International.

[28]  Shibing Yu,et al.  Rapamycin inhibits osteoblast proliferation and differentiation in MC3T3‐E1 cells and primary mouse bone marrow stromal cells , 2008, Journal of cellular biochemistry.

[29]  R. Baron,et al.  A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis. , 2007, Arthritis and rheumatism.

[30]  D. Heath,et al.  An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma. , 2007, Cancer research.

[31]  Akira Yamaguchi,et al.  A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss. , 2006, The Journal of clinical investigation.

[32]  S. Glassman,et al.  Adverse Effects Associated With High-Dose Recombinant Human Bone Morphogenetic Protein-2 Use in Anterior Cervical Spine Fusion , 2006, Spine.

[33]  H. Terai,et al.  Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist. , 2005, Bone.

[34]  J. Fiorellini,et al.  Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. , 2005, Journal of periodontology.

[35]  Hiroyuki Nakaya,et al.  Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. , 2005, Bone.

[36]  T. Griffin,et al.  A comparative study of root coverage with connective tissue and platelet concentrate grafts: 8-month results. , 2004, Journal of periodontology.

[37]  Hongtao Zhang,et al.  Disabling of Receptor Activator of Nuclear Factor-κB (RANK) Receptor Complex by Novel Osteoprotegerin-like Peptidomimetics Restores Bone Loss in Vivo* , 2004, Journal of Biological Chemistry.

[38]  T. Kawamoto,et al.  Use of a new adhesive film for the preparation of multi-purpose fresh-frozen sections from hard tissues, whole-animals, insects and plants. , 2003, Archives of histology and cytology.

[39]  K Ohya,et al.  Synergistic effect of fibroblast growth factor-4 in ectopic bone formation induced by bone morphogenetic protein-2. , 2002, Bone.

[40]  N. Udagawa,et al.  A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. , 1999, Biochemical and biophysical research communications.

[41]  D. Lacey,et al.  Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.

[42]  K Yano,et al.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[43]  R. Murali,et al.  Structure–based design and characterization of exocyclic peptidomimetics that inhibit TNFα binding to its receptor , 1997, Nature Biotechnology.